Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
Ismail
Zahinoor
Z
Syms
Jonathan
J
Blumberger
Daniel
D
George
Tony P
TP
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004326:Drinking / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000209:etiology*; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D016540:Smoking Cessation; D000068580:Varenicline; D014869:Water Intoxication / Q000139:chemically induced*
D014150:Antipsychotic Agents; D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline